Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03747783
Other study ID # Laryngeal cacer
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date January 3, 2013
Est. completion date March 3, 2019

Study information

Verified date November 2018
Source First Affiliated Hospital, Sun Yat-Sen University
Contact Genglong Liu
Phone +8615626405844
Email lglong3@mail2.sysu.edu.cn
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Advanced laryngeal squamous cell carcinoma (SCC) remains a highly morbid and fatal disease despite aggressive interventions. Mortality is high in this cohort: laryngeal cancer affects over 13 000 patients in the United States, with over 3500 deaths annually.The results of the Veterans Affairs Cooperative Studies Program Laryngeal Cancer Trial and subsequent studies demonstrated similar overall survival (OS) rates for organ preservation protocols involving radiotherapy (RT) or chemoradiotherapy (CRT) when compared to surgery, with the benefit of preserving the larynx in a large majority of patients. As such, the use of RT or CRT has become the predominant initial intervention for patients with laryngeal SCC.However, the prognosis of recurrent and persistent laryngeal SCC is particularly dire.In this study,the investigators sought to identify preoperative predictors of survival for patients with recurrent or persistent laryngeal SCC in order to set patient expectations and address modifiable risk factors. Identification of predictors of survival may also identify patients who could benefit from novel therapeutic agents in a neo/adjuvant fashion. Herein,we examine a cohort of patients with recurrent or persistent laryngeal SCC after definitive RT/CRT who has undergone total laryngectomy in order to identify potential preoperative predictors of clinical outcomes.


Description:

Demographic, clinical, and survival data were abstracted. Death was verified via medical records and the social security death index. Primary outcome measures were OS (time from salvage laryngectomy to death from any cause), disease-specific survival (DSS; time from salvage laryngectomy to death from recurrent/persistent laryngeal SCC), and DFS (time from salvage laryngectomy to laryngeal SCC recurrence)


Recruitment information / eligibility

Status Recruiting
Enrollment 400
Est. completion date March 3, 2019
Est. primary completion date January 3, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

- laryngeal carcinoma patients with radical surgery

Exclusion Criteria:

- multiple primarry malignant neo-plasms

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Radical Operation
The surgery treatment selection was based on the American Joint Committee on Cancer stage both of the primary and of the recurrence, as well as on patterns of local spread that were not included in the T classification and on the general condition and preferences of each patient.

Locations

Country Name City State
China Genglong Liu Guangzhou State...

Sponsors (1)

Lead Sponsor Collaborator
First Affiliated Hospital, Sun Yat-Sen University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Overall survival time from laryngectomy to death from any cause Follow up 5 year
See also
  Status Clinical Trial Phase
Completed NCT01089803 - Observational Study of Swallowing Function After Treatment of Advanced Laryngeal Cancer N/A
Completed NCT00026975 - Efficacy of Hyperbaric Oxygen Therapy in Laryngectomy Patients Phase 2
Completed NCT01435252 - A Phase II Study In Patients With Advanced Head And Neck Cancer Of Standard Chemoradiation And Add-On Cetuximab Phase 2
Recruiting NCT04174950 - Perioperative ERAS Based Nursing Intervention for Laryngeal Cancer Patients N/A
Recruiting NCT05857202 - Oxidative Stress and Inflammation Biomarkers in Surgically Treated Patients With Laryngeal Cancer
Recruiting NCT06077643 - Workshops and Exchange Groups for Laryngectomized Patients
Not yet recruiting NCT06137378 - European Larynx Organ Preservation Study (ELOS) [MK-3475-C44] Phase 2
Active, not recruiting NCT02586207 - Pembrolizumab in Combination With CRT for LA-SCCHN Phase 1
Recruiting NCT02012699 - Integrated Cancer Repository for Cancer Research
Recruiting NCT05375266 - Immune Biomarker Study for Head and Neck Cancer
Completed NCT03134976 - Wound Complications in Head and Neck Surgery
Recruiting NCT04650919 - Aortic Laryngeal Rehabilitation Graft N/A
Recruiting NCT05830240 - A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Relapsed/Refractory Head and Neck Cancer Early Phase 1
Terminated NCT02437513 - NewBreez for Airway Protection in Head and Neck Cancer Patients With Chronic Aspiration N/A
Completed NCT01633541 - Chemotherapy AND Bcl-xL Inhibitor (AT-101) For Organ Preservation In Adults With Advanced Laryngeal Cancer Phase 2
Completed NCT01332682 - Resistance Training and Physical Functioning in Head and Neck Cancer Patients Phase 1
Terminated NCT00011492 - Patient Evaluation for Head and Neck Surgery Branch Studies
Recruiting NCT05349487 - SpeakFree Heat and Moisture Exchanger (HME) N/A
Completed NCT00467948 - Comparison of 2 Cefazolin Prophylactic Protocol in Laryngectomy Patients Phase 3
Recruiting NCT06024980 - Using the Subglottic Pressure to Predict the Dysphagia After Partial Laryngectomy N/A